Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin add-on therapy in hospitalized adults with COVID-19
IRCT20201128049508N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ulinastatin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Qom University of Medical Sciences. Primary endpoints: Rehospitalization, Mortality and 2 more. Started Sep 2020; status: completed.
02
Drugs
ulinastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201128049508N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201128049508N1.